Case Study

Innovative’s negotiation power and knowledge of the specialty drug market allowed this client to mitigate much of the cost of one members drug infusions. This resulted in savings of $2.4 million.

Through Innovative’s RFP process and clinical innovation, a health system realized sustained savings that totaled over $34 million.

Innovative renegotiated the TPA’s PBM stifling PBM contract to improve their competitive position in the marketplace and create substantial savings.

A partnership with Innovative allowed the client to maintain a rich benefit for their employees while saving over $14 Million.

Before negotiations, the client’s annual drug cost was nearly $70,000,000. The new contract reduced that cost by $10,543,000 —a decrease of close to 16%.